ArticleJournal of public health research2025
Time to death and its predictors among adult hypertensive patients attending public health facilities, Dire Dawa, Eastern Ethiopia: Retrospective cohort study.
Article in Journal of public health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a significant global health issue, including in Ethiopia, where it remains poorly controlled despite effective treatments, leading to complications and death. This study aimed to estimate time to death and identify predictors among adult hypertensive patients in Dire Dawa, Ethiopia. Method: A retrospective cohort study was conducted among 530 randomly selected adult hypertensive patients from June 28, 2020 to June 28, 2023. Data were collected by Kobo Toolbox and cleaned in Excel, while analysis was done by Stata version 17. The Kaplan-Meier survival curve was computed to estimate the time to death. A log-rank test was used to compare the differences in survival distributions among groups of independent variables. Cox proportional hazards regression models were fitted to identify the predictors of time to death. A Results: The median survival time was 24 months, with a mortality rate of 7.9 per 1000 person-months. Significant independent predictors of mortality included higher education (AHR: 0.17), use of amlodipine (AHR: 0.19), combining amlodipine and hydrochlorothiazide (AHR: 0.17), smoking (AHR: 6.64), alcohol consumption (AHR: 2.66), obesity (AHR: 5.55), being overweight (AHR: 5.66), and having comorbidities (AHR: 3.84). Conclusion: Factors such as education, medication adherence, lifestyle choices, and comorbidities significantly influence mortality among hypertensive patients. Comprehensive management strategies addressing these risk factors are crucial for improving survival in similar healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.